Avastin for Macular
Degeneration - (
Bevacizumab (trade name
Avastin pronounced
"ah-va'-stin") is a medicine used for the
treatment of cancer that targets the angiogenesis pathway.
Macular degeneration, sometimes called just AMD or ARMD (age-related macular
degeneration) is the leading cause of vision loss and blindness in American men
and women above the age of 65. Since the Baby Boomers are getting older and
older and their generation represent an increasingly larger percentage of the
general population, vision loss is a growing problem.
In
October of 2006, the National Eye Institute (NEI) announced that it would
fund a comparative study trial of ranibizumab (Lucentis) and bevacizumab (Avastin)
to assess the effectiveness of the medicines in treating AMD.
clipped from: www.avastin-macular-degeneration.com 